Cargando…
Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment
Adoptive cell transfer (ACT) is a form of personalised immunotherapy which has shown promising results in metastasised cancer. For this treatment, autologous T lymphocytes are selected and stimulated in vitro before re-administration in large numbers. However, only a fraction of patients benefit fro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326979/ https://www.ncbi.nlm.nih.gov/pubmed/30232514 http://dx.doi.org/10.1007/s00251-018-1083-1 |